Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by francois21on Aug 14, 2017 8:01pm

343 Views

Post# 26580806

RE:Does anybody know how much cash PLI have?

PLI should end up with about $55M-$60M in cash.

If you add the $23M from SRAM, we are talking for about 6-9 months of cash ahead.

Now, it's time to deliver some upfront with a deal on 4050.

Bullboard Posts

Rich TV Live's Stocks to Watch this week (June 28, 2024)